Your browser doesn't support javascript.
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars.
Borghetti, Paolo; Guerini, Andrea Emanuele; Sangalli, Claudia; Piperno, Gaia; Franceschini, Davide; La Mattina, Salvatore; Arcangeli, Stefano; Filippi, Andrea Riccardo.
  • Borghetti P; Department of Radiation Oncology, University and Spedali Civili Hospital, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Guerini AE; Department of Radiation Oncology, University and Spedali Civili Hospital, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Sangalli C; Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Piperno G; Division of Radiotherapy, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Franceschini D; Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • La Mattina S; Department of Radiation Oncology, University and Spedali Civili Hospital, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Arcangeli S; Department of Radiation Oncology, School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.
  • Filippi AR; Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
Expert Rev Anticancer Ther ; 22(5): 549-559, 2022 May.
Article in English | MEDLINE | ID: covidwho-1806096
ABSTRACT

INTRODUCTION:

Stage III non-small cell lung cancer (NSCLC) is a variable entity, encompassing bulky primary tumors, nodal involvement, or both. Multidisciplinary evaluation is essential to discuss multiple treatment options, to outline optimal management, and to examine the main debated topics and critical issues not addressed by current trials and guidelines that influence daily clinical practice. AREAS COVERED From March to 5 May 2021 ,meetings were scheduled in a webinar format titled 'Radio Talk' due to the COVID-19 pandemic; the faculty was composed of 6 radiation oncologists from 6 different Institutions of Italy, all of them were the referring radiation oncologist for lung cancer treatment at their respective departments and were or had been members of AIRO (Italian Association of Radiation Oncology) Thoracic Oncology Study Group. The topics covered included pulmonary toxicity, cardiac toxicity, radiotherapy dose, fractionation and volumes, unfit/elderly patients, multidisciplinary management. EXPERT OPINION The debate was focused on the unmet needs triggered by case reports, personal experiences and questions; the answers were often not univocal; however, the exchange of opinion and the contribution of different centers confirmed the role of multidisciplinary management and the necessity that the most critical issues should be investigated in clinical trials.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / COVID-19 / Lung Neoplasms Type of study: Clinical Practice Guide Limits: Aged / Humans Language: English Journal: Expert Rev Anticancer Ther Journal subject: Neoplasms / Therapeutics Year: 2022 Document Type: Article Affiliation country: 14737140.2022.2069098

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / COVID-19 / Lung Neoplasms Type of study: Clinical Practice Guide Limits: Aged / Humans Language: English Journal: Expert Rev Anticancer Ther Journal subject: Neoplasms / Therapeutics Year: 2022 Document Type: Article Affiliation country: 14737140.2022.2069098